Related Experiment Video
Updated: Apr 18, 2026
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
20.8K
Clostridium difficile infection and inflammatory bowel disease.
Camelia Cojocariu1, Carol Stanciu, Oana Stoica
1Grigore T Popa University of Medicine and Pharmacy, Iasi, Romania; St Spiridon Emergency Hospital, Institute of Gastroenterology and Hepatology, Iasi, Romania. stanciucarol@yahoo.com.
Summary
Clostridium difficile infection (CDI) is increasingly severe in inflammatory bowel disease (IBD) patients. Early detection and treatment of CDI during IBD flares are crucial for better outcomes, including reduced colectomy and mortality rates.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Internal Medicine
Background:
- Clostridium difficile infection (CDI) incidence and severity have risen in inflammatory bowel disease (IBD) patients over 15 years.
- IBD patients present unique characteristics and risk factors for CDI compared to non-IBD populations.
- Ulcerative colitis (UC) patients exhibit higher susceptibility and worse outcomes from CDI than Crohn's disease (CD) patients.
Purpose of the Study:
- To review the current literature on CDI in IBD patients.
- To highlight the epidemiology, risk factors, clinical presentation, and diagnostic challenges of CDI in IBD.
- To summarize optimal treatment strategies, outcomes, and prevention measures for CDI in IBD.
Main Methods:
- Comprehensive literature review of studies on CDI in IBD patients.
- Analysis of epidemiological data, risk factors, and clinical outcomes.
- Evaluation of diagnostic approaches and treatment efficacy.
Main Results:
- CDI in IBD patients is associated with increased hospital stay, colectomy rates, and mortality.
- Distinguishing CDI from IBD flares is challenging due to overlapping symptoms, necessitating screening.
- Vancomycin is preferred for severe CDI, while vancomycin and metronidazole show similar efficacy in moderate cases.
Conclusions:
- A high index of suspicion for CDI is vital in IBD patients experiencing flares.
- Prompt diagnosis and treatment of CDI significantly improve clinical outcomes in IBD patients.
- Preventive measures are essential to control the spread of CDI within this vulnerable population.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
2
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:26Inflammatory Bowel Disease I: Introduction
4
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
4
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.6K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.6K
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
3
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
3
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
1
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
1